On this basis, we hypothesize that the increased expression of Chrm3 in our work may be a compensatory response to the degeneration of cholinergic neurons and will have a beneficial effect on the nonmotor symptoms of PD patients, contributing to the maintenance of REM sleep continuity in them (Figure 5). This evidence concerns the gene CHRM3 and Parkinson disease.